Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BICTEGRAVIR vs BINIMETINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BICTEGRAVIR vs BINIMETINIB: Safety Overview

Metric BICTEGRAVIR BINIMETINIB
Total FAERS Reports 116 6,914
Deaths Reported 13 1,069
Death Rate 11.2% 15.5%
Hospitalizations 36 1,990
Average Patient Age 45.8 yrs 63.0 yrs
% Female Patients 26.4% 47.7%
FDA Approval Date N/A Jun 27, 2018
Manufacturer Gilead Sciences, Inc. Array BioPharma Inc.
Route ORAL ORAL
Marketing Status N/A Prescription